Studies

SARS-CoV-2 COVID-19

The R&D team of Laboratoires Réunis is involved in several national and international medical and scientific collaborations on the SARS-CoV-II epidemic.

For more information: Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.pdf

Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice - Which to Use Regarding Disease Outcomes?

Click here to download the PDF